The FORWARD Biobank includes samples from participants with a wide variety of rheumatic and musculoskeletal diseases. We have been collecting samples since 2010, and they are associated with longitudinal questionnaires. These diagnoses include, but are not limited to:
We have multiple sample types derived from whole blood for each participant, including RNA-stabilized samples, DNA-stabilized samples, serum EDTA plasma, cryopreserved white blood cells, and isolated DNA.
We have serological marker measures (including CRP, RF, and anti-CCP) and high resolution HLA-DRB1 typing (shared epitope) available for all Biobank participants, and genotyping data available for many.
Kristin Wipfler, PhD
Dr. Wipfler designs and directs research studies related to FORWARD biosamples and provides analytical support for additional epidemiological studies and collaborations. For more information on the FORWARD Biobank, please email her at [email protected]